Skip to main content
Top
Published in: Tobacco Induced Diseases 1/2013

Open Access 01-12-2013 | Research

Older smokers could be the strongest supporters for U.S. government regulation of tobacco: a focus group study

Authors: Valerie B Yerger, Janine K Cataldo, Ruth E Malone

Published in: Tobacco Induced Diseases | Issue 1/2013

Login to get access

Abstract

Background

Targeting of marginalized groups with aggressive tobacco marketing has been identified as exacerbating health disparities. However, interpretation of such targeting by groups varies, from surprise and outrage to regarding such marketing as evidence of social legitimacy. We sought to learn how an often-overlooked marginalized group, older adults, would respond to industry documents offering evidence of tobacco company target marketing.

Methods

We conducted 10 focus groups in California cities with older (≥50 years) smokers and former smokers. A set of previously-undisclosed tobacco industry documents related to target marketing was shown to the group in sequence. Audiotaped discussions were transcribed and data analyzed using qualitative approaches.

Results

Responses to evidence of tobacco industry targeting varied, with some regarding it as exploitive and others as normal business practice. However, in most groups, discussions turned to government’s failure to protect the public—even though government action /inaction was not prompted nor addressed in the discussion documents.

Conclusion

Given the Food and Drug Administration’s new authority to regulate tobacco products, these findings suggest that some of the tobacco industry’s “best customers” (older, established smokers and ex-smokers) may be strong supporters of government regulation of tobacco.
Literature
1.
go back to reference Dawel A, Anstey KJ: Interventions for midlife smoking cessation: a literature review. Aust Psychol. 2011, 46 (3): 190-195. 10.1111/j.1742-9544.2010.00014.x.CrossRef Dawel A, Anstey KJ: Interventions for midlife smoking cessation: a literature review. Aust Psychol. 2011, 46 (3): 190-195. 10.1111/j.1742-9544.2010.00014.x.CrossRef
2.
go back to reference Doll R, Peto R, Boreham J, Sutherland I: Mortality in relation to smoking: 50 years’ observations on male British doctors. J Epidemiol Community Health. 2004, 58 (11): 930-930.PubMedCentral Doll R, Peto R, Boreham J, Sutherland I: Mortality in relation to smoking: 50 years’ observations on male British doctors. J Epidemiol Community Health. 2004, 58 (11): 930-930.PubMedCentral
3.
go back to reference Critchley JA, Capewell S: Mortality risk reduction associated with smoking cessation in patients with coronary heart disease: a systematic review. JAMA. 2003, 290 (1): 86-97. 10.1001/jama.290.1.86.CrossRefPubMed Critchley JA, Capewell S: Mortality risk reduction associated with smoking cessation in patients with coronary heart disease: a systematic review. JAMA. 2003, 290 (1): 86-97. 10.1001/jama.290.1.86.CrossRefPubMed
4.
go back to reference Eliasson B, Hjalmarson A, Kruse E, Landfeldt B, Westin A: Effect of smoking reduction and cessation on cardiovascular risk factors. Nicotine Tob Res. 2001, 3 (3): 249-255.CrossRefPubMed Eliasson B, Hjalmarson A, Kruse E, Landfeldt B, Westin A: Effect of smoking reduction and cessation on cardiovascular risk factors. Nicotine Tob Res. 2001, 3 (3): 249-255.CrossRefPubMed
5.
go back to reference Kerr S, Watson H, Tolson D, Lough M, Brown M: Smoking after the age of 65 years: a qualitative exploration of older current and former smokers’ views on smoking, stopping smoking, and smoking cessation resources and services. Health Soc Care Community. 2006, 14 (6): 572-582. 10.1111/j.1365-2524.2006.00659.x.CrossRefPubMed Kerr S, Watson H, Tolson D, Lough M, Brown M: Smoking after the age of 65 years: a qualitative exploration of older current and former smokers’ views on smoking, stopping smoking, and smoking cessation resources and services. Health Soc Care Community. 2006, 14 (6): 572-582. 10.1111/j.1365-2524.2006.00659.x.CrossRefPubMed
6.
go back to reference Cataldo JK, Bero LA, Malone RE: A delicate diplomatic situation”: tobacco industry efforts to gain control of the Framingham Study. J Clin Epidemiol. 2010, 63 (8): 841-853. 10.1016/j.jclinepi.2010.01.021.PubMedCentralCrossRefPubMed Cataldo JK, Bero LA, Malone RE: A delicate diplomatic situation”: tobacco industry efforts to gain control of the Framingham Study. J Clin Epidemiol. 2010, 63 (8): 841-853. 10.1016/j.jclinepi.2010.01.021.PubMedCentralCrossRefPubMed
7.
go back to reference Cataldo JK, Malone RE: False promises: the tobacco industry, “low tar” cigarettes, and older smokers. J Am Geriatr Soc. 2008, 56 (9): 1716-1723. 10.1111/j.1532-5415.2008.01850.x.PubMedCentralCrossRefPubMed Cataldo JK, Malone RE: False promises: the tobacco industry, “low tar” cigarettes, and older smokers. J Am Geriatr Soc. 2008, 56 (9): 1716-1723. 10.1111/j.1532-5415.2008.01850.x.PubMedCentralCrossRefPubMed
8.
go back to reference Etter JF, Bullen C: Electronic cigarette: users profile, utilization, satisfaction and perceived efficacy. Addict. 2011, 106 (11): 2017-2028. 10.1111/j.1360-0443.2011.03505.x.CrossRef Etter JF, Bullen C: Electronic cigarette: users profile, utilization, satisfaction and perceived efficacy. Addict. 2011, 106 (11): 2017-2028. 10.1111/j.1360-0443.2011.03505.x.CrossRef
10.
go back to reference Regan AK, Promoff G, Dube SR, Arrazola R: Electronic nicotine delivery systems: adult use and awareness of the ‘e-cigarette’ in the USA. Tob Control. 2013, 22 (1): 19-23. 10.1136/tobaccocontrol-2011-050044.CrossRefPubMed Regan AK, Promoff G, Dube SR, Arrazola R: Electronic nicotine delivery systems: adult use and awareness of the ‘e-cigarette’ in the USA. Tob Control. 2013, 22 (1): 19-23. 10.1136/tobaccocontrol-2011-050044.CrossRefPubMed
11.
go back to reference Al-Delaimy WK, Pierce JP, Messer K, White MM, Trinidad DR, Gilpin EA: The California Tobacco Control Program’s effect on adult smokers: (2) daily cigarette consumption levels. Tob Control. 2007, 16 (2): 91-95. 10.1136/tc.2006.017061.PubMedCentralCrossRefPubMed Al-Delaimy WK, Pierce JP, Messer K, White MM, Trinidad DR, Gilpin EA: The California Tobacco Control Program’s effect on adult smokers: (2) daily cigarette consumption levels. Tob Control. 2007, 16 (2): 91-95. 10.1136/tc.2006.017061.PubMedCentralCrossRefPubMed
12.
go back to reference Anderson SJ, Glantz SA, Ling PM: Emotions for sale: cigarette advertising and women’s psychosocial needs. Tob Control. 2005, 14 (2): 127-135. 10.1136/tc.2004.009076.PubMedCentralCrossRefPubMed Anderson SJ, Glantz SA, Ling PM: Emotions for sale: cigarette advertising and women’s psychosocial needs. Tob Control. 2005, 14 (2): 127-135. 10.1136/tc.2004.009076.PubMedCentralCrossRefPubMed
13.
go back to reference Sepe E, Ling PM, Glantz SA: Smooth moves: bar and nightclub tobacco promotions that target young adults. Am J Public Health. 2002, 92 (3): 414-419. 10.2105/AJPH.92.3.414.PubMedCentralCrossRefPubMed Sepe E, Ling PM, Glantz SA: Smooth moves: bar and nightclub tobacco promotions that target young adults. Am J Public Health. 2002, 92 (3): 414-419. 10.2105/AJPH.92.3.414.PubMedCentralCrossRefPubMed
14.
go back to reference Pierce JP: Tobacco industry marketing, population-based tobacco control, and smoking behavior. Am J Prev Med. 2007, 33 (Suppl 6): 327-334.CrossRef Pierce JP: Tobacco industry marketing, population-based tobacco control, and smoking behavior. Am J Prev Med. 2007, 33 (Suppl 6): 327-334.CrossRef
15.
go back to reference Apollonio DE, Malone RE: Marketing to the marginalised: tobacco industry targeting of the homeless and mentally ill. Tob Control. 2005, 14 (6): 409-415. 10.1136/tc.2005.011890.PubMedCentralCrossRefPubMed Apollonio DE, Malone RE: Marketing to the marginalised: tobacco industry targeting of the homeless and mentally ill. Tob Control. 2005, 14 (6): 409-415. 10.1136/tc.2005.011890.PubMedCentralCrossRefPubMed
16.
go back to reference Balbach ED, Gasior RJ, Barbeau EM: R.J. Reynolds’ targeting of African Americans. Am J Public Health. 2003, 93 (5): 822-827. 10.2105/AJPH.93.5.822. 1988-2000PubMedCentralCrossRefPubMed Balbach ED, Gasior RJ, Barbeau EM: R.J. Reynolds’ targeting of African Americans. Am J Public Health. 2003, 93 (5): 822-827. 10.2105/AJPH.93.5.822. 1988-2000PubMedCentralCrossRefPubMed
17.
go back to reference Fernandez S, Hickman N, Klonoff EA, Landrine H, Kashima K, Parekh B, Brouillard CR, Zolezzi M, Jensen JA, Weslowski Z: Cigarette advertising in magazines for Latinas, White women, and men, 1998–2002: a preliminary investigation. J Community Health. 2005, 30 (2): 141-151. 10.1007/s10900-004-1097-5.CrossRefPubMed Fernandez S, Hickman N, Klonoff EA, Landrine H, Kashima K, Parekh B, Brouillard CR, Zolezzi M, Jensen JA, Weslowski Z: Cigarette advertising in magazines for Latinas, White women, and men, 1998–2002: a preliminary investigation. J Community Health. 2005, 30 (2): 141-151. 10.1007/s10900-004-1097-5.CrossRefPubMed
18.
go back to reference Landrine H, Klonoff EA, Fernandez S, Hickman N, Kashima K, Parekh B, Thomas K, Brouillard CR, Zolezzi M, Jensen JA, Weslowski Z: Cigarette advertising in Black, Latino, and White magazines, 1998-2002: an exploratory investigation. Ethn Dis. 2005, 15 (1): 63-67.PubMed Landrine H, Klonoff EA, Fernandez S, Hickman N, Kashima K, Parekh B, Thomas K, Brouillard CR, Zolezzi M, Jensen JA, Weslowski Z: Cigarette advertising in Black, Latino, and White magazines, 1998-2002: an exploratory investigation. Ethn Dis. 2005, 15 (1): 63-67.PubMed
19.
go back to reference Portugal C, Cruz TB, Espinoza L, Romero M, Baezconde Garbanati L: Countering tobacco industry sponsorship of Hispanic/Latino organizations through policy adoption: a case study. Health Promot Pract. 2004, 5 (Supple 3): 143-156.CrossRef Portugal C, Cruz TB, Espinoza L, Romero M, Baezconde Garbanati L: Countering tobacco industry sponsorship of Hispanic/Latino organizations through policy adoption: a case study. Health Promot Pract. 2004, 5 (Supple 3): 143-156.CrossRef
20.
go back to reference Smith EA, Offen N, Malone RE: Pictures worth a thousand words: noncommercial tobacco content in the lesbian, gay, and bisexual press. J Health Commun. 2006, 11 (7): 635-649. 10.1080/10810730600934492.PubMedCentralCrossRefPubMed Smith EA, Offen N, Malone RE: Pictures worth a thousand words: noncommercial tobacco content in the lesbian, gay, and bisexual press. J Health Commun. 2006, 11 (7): 635-649. 10.1080/10810730600934492.PubMedCentralCrossRefPubMed
22.
go back to reference Yerger VB, Przewoznik J, Malone RE: Racialized geography, corporate activity, and health disparities: tobacco industry targeting of inner cities. J Health Care Poor Underserved. 2007, 18 (Suppl 4): 10-38.CrossRefPubMed Yerger VB, Przewoznik J, Malone RE: Racialized geography, corporate activity, and health disparities: tobacco industry targeting of inner cities. J Health Care Poor Underserved. 2007, 18 (Suppl 4): 10-38.CrossRefPubMed
23.
go back to reference Yerger VB, Daniel MR, Malone RE: Taking it to the streets: responses of African American young adults to internal tobacco industry documents. Nicotine Tob Res. 2005, 7 (1): 163-172. 10.1080/14622200412331328385.CrossRefPubMed Yerger VB, Daniel MR, Malone RE: Taking it to the streets: responses of African American young adults to internal tobacco industry documents. Nicotine Tob Res. 2005, 7 (1): 163-172. 10.1080/14622200412331328385.CrossRefPubMed
24.
go back to reference Smith EA, Thomson K, Offen N, Malone RE: If you know you exist, it’s just marketing poison”: meanings of tobacco industry targeting in the lesbian, gay, bisexual, and transgender community. Am J Public Health. 2008, 98 (6): 996-1003. 10.2105/AJPH.2007.118174.PubMedCentralCrossRefPubMed Smith EA, Thomson K, Offen N, Malone RE: If you know you exist, it’s just marketing poison”: meanings of tobacco industry targeting in the lesbian, gay, bisexual, and transgender community. Am J Public Health. 2008, 98 (6): 996-1003. 10.2105/AJPH.2007.118174.PubMedCentralCrossRefPubMed
25.
go back to reference Schroeder S: Stranded in the periphery–the increasing marginalization of smokers. N Engl J Med. 2008, 358 (21): 2284-2286. 10.1056/NEJMe0802708.CrossRefPubMed Schroeder S: Stranded in the periphery–the increasing marginalization of smokers. N Engl J Med. 2008, 358 (21): 2284-2286. 10.1056/NEJMe0802708.CrossRefPubMed
27.
go back to reference Al-Delaimy W, White M, Mills A, Pierce J, Emory K, Boman M, Smith J, Edland S: Final Summary Report of: Two Decades of the California Tobacco Control Program: California Tobacco Survey, 1990-2008. 2010, La Jolla: University of California, San Diego Al-Delaimy W, White M, Mills A, Pierce J, Emory K, Boman M, Smith J, Edland S: Final Summary Report of: Two Decades of the California Tobacco Control Program: California Tobacco Survey, 1990-2008. 2010, La Jolla: University of California, San Diego
28.
go back to reference Morgan DL: The focus group guidebook. 1998, Thousand Oaks: Sage PublicationsCrossRef Morgan DL: The focus group guidebook. 1998, Thousand Oaks: Sage PublicationsCrossRef
29.
go back to reference Morgan DL: Focus groups as qualitative research. 1997, Thousand Oaks: Sage Publications Morgan DL: Focus groups as qualitative research. 1997, Thousand Oaks: Sage Publications
30.
go back to reference Anderson SJ, McCandless PM, Taketa RM, Klausner K, Salgado MV, Butter K, Yerger VB: Tobacco documents research methodology. Tob Control. 2011, 20 (Suppl 2): 8-11. Anderson SJ, McCandless PM, Taketa RM, Klausner K, Salgado MV, Butter K, Yerger VB: Tobacco documents research methodology. Tob Control. 2011, 20 (Suppl 2): 8-11.
42.
go back to reference Chan C, Brykczynski K, Malone RE, Benner P: (Interpretive phenomenology in health care research. 2010, Indianapolis: Sigma Theta Tau International Press Chan C, Brykczynski K, Malone RE, Benner P: (Interpretive phenomenology in health care research. 2010, Indianapolis: Sigma Theta Tau International Press
43.
go back to reference Benner P: Interpretive phenomenology: embodiment, caring, and ethics in health and illness. 1994, Thousand Oaks: Sage Publications Benner P: Interpretive phenomenology: embodiment, caring, and ethics in health and illness. 1994, Thousand Oaks: Sage Publications
44.
go back to reference Rabinow P, Sullivan WM: The interpretive turn: a second look. Interpretive social science: a second look. Edited by: Rabinow P, Sullivan WM. 1987, Berkeley: University of California Press, 1-30. Rabinow P, Sullivan WM: The interpretive turn: a second look. Interpretive social science: a second look. Edited by: Rabinow P, Sullivan WM. 1987, Berkeley: University of California Press, 1-30.
45.
go back to reference Jennings BL: Interpretive social science and policy analysis. Ethics, the social sciences, and policy analysis. Edited by: Callahan D, Jennings B. 1983, New York: Plenum Press, 3-35.CrossRef Jennings BL: Interpretive social science and policy analysis. Ethics, the social sciences, and policy analysis. Edited by: Callahan D, Jennings B. 1983, New York: Plenum Press, 3-35.CrossRef
46.
go back to reference NVivo 8: QSR International. 2008, Melbourne, Australia: QS Research NVivo 8: QSR International. 2008, Melbourne, Australia: QS Research
47.
go back to reference Hiscock R, Bauld L, Amos A, Fidler JA, Munafo M: Socioeconomic status and smoking: a review. Ann NY Acad Sci. 2012, 1248: 107-123. 10.1111/j.1749-6632.2011.06202.x.CrossRefPubMed Hiscock R, Bauld L, Amos A, Fidler JA, Munafo M: Socioeconomic status and smoking: a review. Ann NY Acad Sci. 2012, 1248: 107-123. 10.1111/j.1749-6632.2011.06202.x.CrossRefPubMed
48.
go back to reference Cataldo JK, Slaughter R, Jahan TM, Pongquan VL, Hwang WJ: Measuring stigma in people with lung cancer: psychometric testing of the cataldo lung cancer stigma scale. Oncol Nurs Forum. 2011, 38 (1): E46-54. 10.1188/11.ONF.E46-E54.PubMedCentralCrossRefPubMed Cataldo JK, Slaughter R, Jahan TM, Pongquan VL, Hwang WJ: Measuring stigma in people with lung cancer: psychometric testing of the cataldo lung cancer stigma scale. Oncol Nurs Forum. 2011, 38 (1): E46-54. 10.1188/11.ONF.E46-E54.PubMedCentralCrossRefPubMed
49.
go back to reference Else-Quest NM, LoConte NK, Schiller JH, Hyde JS: Perceived stigma, self-blame, and adjustment among lung, breast and prostate cancer patients. Psychol Health. 2009, 24 (8): 949-964. 10.1080/08870440802074664.CrossRefPubMed Else-Quest NM, LoConte NK, Schiller JH, Hyde JS: Perceived stigma, self-blame, and adjustment among lung, breast and prostate cancer patients. Psychol Health. 2009, 24 (8): 949-964. 10.1080/08870440802074664.CrossRefPubMed
50.
go back to reference Halding AG, Heggdal K, Wahl A: Experiences of self-blame and stigmatisation for self-infliction among individuals living with COPD. Scand J Caring Sci. 2011, 25 (1): 100-107. 10.1111/j.1471-6712.2010.00796.x.CrossRefPubMed Halding AG, Heggdal K, Wahl A: Experiences of self-blame and stigmatisation for self-infliction among individuals living with COPD. Scand J Caring Sci. 2011, 25 (1): 100-107. 10.1111/j.1471-6712.2010.00796.x.CrossRefPubMed
51.
go back to reference United States District Court for the District of Columbia, United States of America, Plaintiff, and Tobacco-Free Kids Fund, American Cancer Society, American Heart Association, American Lung Association, Americans for Nonsmokers’ Rights, and National African American Tobacco Prevention Network, Interveners U.S.v. Philip Morris USA, Inc: Defendants: Civil Action No. 99-CV-02496 (GK). US Dist Court Dist Columbia. 2006, 449: i-2454. United States District Court for the District of Columbia, United States of America, Plaintiff, and Tobacco-Free Kids Fund, American Cancer Society, American Heart Association, American Lung Association, Americans for Nonsmokers’ Rights, and National African American Tobacco Prevention Network, Interveners U.S.v. Philip Morris USA, Inc: Defendants: Civil Action No. 99-CV-02496 (GK). US Dist Court Dist Columbia. 2006, 449: i-2454.
52.
go back to reference Family Smoking Prevention and Tobacco Control Act. Public Law No. 111-31, div. A, sec. 2(1), (2), (13)&(14), (6)-(7), 123 Stat. 1776, 1777. 2009, . Family Smoking Prevention and Tobacco Control Act. Public Law No. 111-31, div. A, sec. 2(1), (2), (13)&(14), (6)-(7), 123 Stat. 1776, 1777. 2009, .
55.
go back to reference Chapman S, Freeman B: Markers of the denormalisation of smoking and the tobacco industry. Tob Control. 2008, 17 (1): 25-31. 10.1136/tc.2007.021386.CrossRefPubMed Chapman S, Freeman B: Markers of the denormalisation of smoking and the tobacco industry. Tob Control. 2008, 17 (1): 25-31. 10.1136/tc.2007.021386.CrossRefPubMed
56.
go back to reference Malone RE, Grundy Q, Bero LA: Tobacco industry denormalisation as a tobacco control intervention: a review. Tob Control. 2012, 21 (2): 162-170. 10.1136/tobaccocontrol-2011-050200.PubMedCentralCrossRefPubMed Malone RE, Grundy Q, Bero LA: Tobacco industry denormalisation as a tobacco control intervention: a review. Tob Control. 2012, 21 (2): 162-170. 10.1136/tobaccocontrol-2011-050200.PubMedCentralCrossRefPubMed
57.
go back to reference Roeseler A, Burns D: The quarter that changed the world. Tob Control. 2010, 19 (Suppl 1): 3-15.CrossRef Roeseler A, Burns D: The quarter that changed the world. Tob Control. 2010, 19 (Suppl 1): 3-15.CrossRef
Metadata
Title
Older smokers could be the strongest supporters for U.S. government regulation of tobacco: a focus group study
Authors
Valerie B Yerger
Janine K Cataldo
Ruth E Malone
Publication date
01-12-2013
Publisher
BioMed Central
Published in
Tobacco Induced Diseases / Issue 1/2013
Electronic ISSN: 1617-9625
DOI
https://doi.org/10.1186/1617-9625-11-17

Other articles of this Issue 1/2013

Tobacco Induced Diseases 1/2013 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine